Cargando…
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway
BACKGROUND: Severe coronavirus disease 2019 (COVID-19) is characterized by impaired type I interferon activity and a state of hyperinflammation leading to acute respiratory distress syndrome. The complement system has recently emerged as a key player in triggering and maintaining the inflammatory st...
Autores principales: | Boussier, Jeremy, Yatim, Nader, Marchal, Armance, Hadjadj, Jérôme, Charbit, Bruno, El Sissy, Carine, Carlier, Nicolas, Pène, Frédéric, Mouthon, Luc, Tharaux, Pierre-Louis, Bergeron, Anne, Smadja, David M., Rieux-Laucat, Frédéric, Duffy, Darragh, Kernéis, Solen, Frémeaux-Bacchi, Véronique, Terrier, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595971/ https://www.ncbi.nlm.nih.gov/pubmed/34800432 http://dx.doi.org/10.1016/j.jaci.2021.11.004 |
Ejemplares similares
-
Activation de la voie alterne du complément dans les formes sévères de COVID-19
por: Boussier, J., et al.
Publicado: (2021) -
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients
por: Courties, Alice, et al.
Publicado: (2021) -
Platelet activation in critically ill COVID-19 patients
por: Yatim, Nader, et al.
Publicado: (2021) -
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
por: Hadjadj, Jérôme, et al.
Publicado: (2020) -
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection
por: Smith, Nikaïa, et al.
Publicado: (2021)